ISMP Newsroom

Safe medication practices depend on communication within the healthcare community, including patients and their families. ISMP is at the forefront of medication error reporting and guidance on safe medication practices, and is often cited in the media as a reputable resource for current information and emerging trends. In 2020, ISMP formally affiliated with ECRI to create one of the largest quality and safety entities in the world. ISMP's Newsroom includes ISMP and ECRI news releases, as well as ISMP blog posts, statements, and other communications. 

To schedule an interview or request to be added to ISMP’s news release distribution lists, contact Renee Brehio.

Recent Updates

Filter by type
A study led by ISMP senior scientist Thomas J. Moore and published in JAMA Internal Medicine estimates the costs of pivotal clinical trials that the FDA relies on to prove the benefits of new drugs.
A white paper recently released by ISMP stresses the need for Medication Safety Officers to be included as an integral part of the healthcare team and provides detailed information for hospital leadership on the value of creating a dedicated position directly responsible for and empowered to lead medication safety strategy and implementation.
The International Medication Safety Network (IMSN) and the US Food and Drug Administration (FDA) held a summit for regulators on drug container labeling and packaging safety on June 19 and 20, 2018, to advance global harmonization of standards and reduce overall harm associated with medication errors.
A study published as an online first in JAMA Internal Medicine shows that 77% of patients taking zolpidem (known by the brand names of Ambien, Edluar and Zolpimist), the most widely used prescription sleep medication, were not observing FDA recommendations to promote safe use.